🔎 Trials Near Me

Akèy › Kansè Poumon ki pa ti selil › Kalifòni › Concord

Etid klinik pou Kansè Poumon ki pa ti selil nan Concord, CA

14 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Concord (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Ap rekriteFaz 3
  • Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi lwen
  • John Muir Medical Center-Walnut Creek, Walnut Creek · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT04267848

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Ap rekriteFaz 3
  • Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06498635

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Ap rekriteFaz 3
  • Local Institution - 0208, Pleasant Hill · 3 mi lwen
  • BASS Cancer Center, Walnut Creek · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07361510

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Ap rekriteFaz 3
  • John Muir Health Clinical Research Center, Concord
  • John Muir Health Cancer Center, Walnut Creek · 5 mi lwen
  • John Muir Health Clinical Research Center, Walnut Creek · 5 mi lwen
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07144280

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Ap rekriteFaz 2
  • Kaiser Permanente Walnut Creek Medical Center, Walnut Creek · 5 mi lwen
  • John Muir Health Clinical Research Center, Walnut Creek · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06667076

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Ap rekriteFaz 3
  • BASS Cancer Center, Walnut Creek · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06890598

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer

Ap rekriteEtid obsèvasyon
  • John Muir Health, Walnut Creek · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07028489

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Ap rekriteFaz 2/3
  • John Muir Clinical Research Center, Concord
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06712316

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Ap rekriteFaz 3
  • Research Site, Walnut Creek · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06692738

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Ap rekriteFaz 3
  • BASS Cancer Center, Walnut Creek · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

Ap rekriteFaz 3
  • Research Site, Walnut Creek · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06350097

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Ap rekriteFaz 2
  • Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jun 3, 2026 · NCT05642572

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Ap rekriteEtid obsèvasyon
  • Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi lwen
  • Contra Costa Regional Medical Center, Martinez · 6 mi lwen
  • Contra Costa Regional Medical Center, Martinez · 6 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT06418204

Etid Kansè Poumon ki pa ti selil nan lòt vil

Lòt etid nan Concord

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.